Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Selexipag TDA Impurity; Selexipag O-TDA Impurity
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Selexipag O - Impurity is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Selexipag O - Impurity usage and description
Selexipag O is an impurity that is commonly found in pharmaceutical preparations of the drug Selexipag. Selexipag is a medication that is used to treat pulmonary arterial hypertension, a condition characterized by high blood pressure in the pulmonary arteries that supply blood to the lungs. Selexipag works by activating a specific receptor in the body known as the prostacyclin receptor, which helps to dilate the blood vessels and reduce blood pressure.
Selexipag O is an impurity that is formed during the synthesis of Selexipag. It is a chemical compound that is structurally similar to Selexipag but differs in its chemical composition. Selexipag O is considered an unwanted impurity in Selexipag preparations as it can alter the pharmacological properties of the drug and potentially cause adverse effects.
Chemically, Selexipag O is a derivative of Selexipag that contains a hydroxyl group (-OH) attached to the aromatic ring of the molecule. This hydroxyl group can significantly alter the physicochemical properties of the molecule and may affect its solubility, stability, and bioavailability.
In conclusion, Selexipag O is an unwanted impurity that can be found in Selexipag preparations. Its presence can affect the pharmacological properties of the drug and may cause adverse effects. Therefore, it is essential to monitor and control the levels of Selexipag O in Selexipag preparations to ensure the safety and efficacy of the medication.
